Why the study?
Does sublingual nifedipine reduce blood pressure and alter plasma renin activity in patients with hypertension?
Does sublingual nifedipine reduce blood pressure and alter plasma renin activity in patients with hypertension?
Sublingual nifedipine effectively lowers blood pressure in various forms of hypertension while reflexively increasing heart rate and plasma renin activity.
Answers are grounded in this paper and cite their sources.
May support acute BP reduction with nifedipine; single case leaves open net clinical benefit and renin effects.
The Ca2+ antagonistic coronary vasodilator, Nifedipine, was sublingually administered by a dose of 30 mg to 19 patients with hypertension. Blood pressure of patients with with essential hypertension (n=14) decreased from 177 +/- 24 to 123 +/- 13 mmHg systolic and from 108 +/- 12 to 80 +/- 11 mmHg diastolic (mean +/- SD) (p less than 0.01). Plasma renin activity (PRA) increased significantly from 0.73 +/- 0.62 to 1.50 +/- 1.02 ng/ml/h (p less than 0.05). The same tendency was observed in malignant and renovascular hypertension. In primary aldosteronism (n = 2), blood pressure decreased but PRA did not increase. Hypotensive action and increased plasma renin activity by Ca2+ antagonist, Nifedipine, were clearly demonstrated in patients with hypertension.
No takes yet. Share an insight, caveat, or question.
Aoki et al. (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: